The introduction of Wegovy, an oral pill for weight loss, has sparked interest in the UAE, with prices ranging from Dh779 to Dh1,610 depending on the prescribed dosage. This new treatment option, which is now available in the UAE, has been met with strong demand, particularly from individuals who have never sought weight-loss treatment before. The oral format of Wegovy is seen as a more accessible and appealing alternative to injections, with pharmacies reporting a surge in inquiries and prescriptions. This trend is supported by healthcare providers, with digital health platforms recording a high volume of patients on waiting lists. The strong interest in Wegovy highlights a growing demand for medically supervised weight-management treatments and expanded obesity care options across the UAE. However, the question remains whether the supply of Wegovy will be sufficient to meet the rising demand. Pharmacies have been advised to secure stocks early due to the strong overall demand, and it is expected that the trend will continue in the coming weeks. This new treatment option has the potential to revolutionize weight-loss management in the UAE, offering a more convenient and accessible approach to addressing obesity and overweight issues.
